Stress-induced hyperglycaemia and venous thromboembolism following total hip or total knee arthroplasty: analysis from the RECORD trials
- PMID: 22187097
- DOI: 10.1160/TH11-07-0447
Stress-induced hyperglycaemia and venous thromboembolism following total hip or total knee arthroplasty: analysis from the RECORD trials
Abstract
Stress-induced hyperglycaemia is common during orthopaedic surgery. In addition, hyperglycaemia activates coagulation. The aim of the study was to assess whether stress-induced hyperglycaemia is associated with symptomatic or asymptomatic venous thromboembolism (VTE) following orthopaedic surgery. We performed post-hoc analyses in the four RECORD studies (REgulation of Coagulation in major Orthopaedic surgery reducing the Risk of Deep venous thrombosis and pulmonary embolism). Separate analyses were performed for patients undergoing elective total hip or knee replacement. Outcome measures were symptomatic VTE and "total VTE" (defined as the composite of symptomatic VTE, asymptomatic DVT assessed by per protocol venography and all cause mortality). Glucose levels were measured pre-op and 6 hours post-op, categorised into quartiles, based on the distribution in the respective cohorts. The influence of glucose, adjusted for body mass index, age, gender and diabetes mellitus on VTE was assessed by logistic regression analyses. A total of 12,383 patients were eligible for assessment of symptomatic VTE, and 8,512 patients were eligible for assessment of total VTE. Increased glucose levels after total hip replacement were associated with total VTE; adjusted odds ratio (OR) highest versus lowest quartile 1.9 (95% confidence interval [CI] 1.3 to 3.0). Furthermore, increase in glucose levels during total hip replacement was associated with total VTE (OR highest versus lowest quartile 1.8 (95%CI 1.2 to 2.8). This was not observed in patients undergoing total knee replacement, probably due to differences in the applied surgical procedures.
Similar articles
-
Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population.J Med Econ. 2011;14(3):324-34. doi: 10.3111/13696998.2011.578698. Epub 2011 Apr 20. J Med Econ. 2011. PMID: 21506632
-
Population-based epidemiology of postoperative venous thromboembolism in Taiwanese patients receiving hip or knee arthroplasty without pharmacological thromboprophylaxis.Thromb Res. 2014 May;133(5):719-24. doi: 10.1016/j.thromres.2014.01.039. Epub 2014 Feb 5. Thromb Res. 2014. PMID: 24593913
-
Venous thromboembolism and bleeding after total knee and hip arthroplasty. Findings from the Spanish National Discharge Database.Thromb Haemost. 2011 Apr;105(4):610-5. doi: 10.1160/TH10-10-0645. Epub 2010 Dec 21. Thromb Haemost. 2011. PMID: 21174008
-
Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.Semin Vasc Med. 2005 Aug;5(3):266-75. doi: 10.1055/s-2005-916166. Semin Vasc Med. 2005. PMID: 16123914 Review.
-
Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty.Am J Manag Care. 2011 Feb;17(1 Suppl):S22-6. Am J Manag Care. 2011. PMID: 21517652 Review.
Cited by
-
High level of neutrophil to lymphocyte ratio increases the risk of deep venous thrombosis in intensive care unit patients after oral cancer surgery: a retrospective study.Ann Transl Med. 2022 Jul;10(14):763. doi: 10.21037/atm-22-2453. Ann Transl Med. 2022. PMID: 35965831 Free PMC article.
-
Risk factors for perioperative hyperglycemia in primary hip and knee replacements.Acta Orthop. 2015 Apr;86(2):175-82. doi: 10.3109/17453674.2014.987064. Epub 2014 Nov 18. Acta Orthop. 2015. PMID: 25409255 Free PMC article.
-
Association between hyperglycemia on admission and preoperative deep venous thrombosis in patients with femoral neck fractures.BMC Musculoskelet Disord. 2022 Oct 6;23(1):899. doi: 10.1186/s12891-022-05862-0. BMC Musculoskelet Disord. 2022. PMID: 36203137 Free PMC article.
-
Glucose levels and diabetes are not associated with the risk of venous thrombosis: results from the MEGA case-control study.Br J Haematol. 2019 Feb;184(3):431-435. doi: 10.1111/bjh.15599. Epub 2018 Nov 27. Br J Haematol. 2019. PMID: 30478992 Free PMC article. Clinical Trial.
-
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.Cochrane Database Syst Rev. 2016 Mar 30;3(3):CD004179. doi: 10.1002/14651858.CD004179.pub2. Cochrane Database Syst Rev. 2016. PMID: 27027384 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous